Lijun Zhang

1 ta ish

United States Food and Drug Administration

1. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

   Patricia Cortazar, Lijun Zhang, Michael Untch +34

   Sharh maqola20144 iqtibos

   ABIABI:AkademIndex/2026.other.434433